NCT00649896View on ClinicalTrials.gov

Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Healthy
Interventions
DRUG

Mylan Estradiol Transdermal System 0.025 mg/day

DRUG

Climara® Transdermal System 0.025 mg/day

Trial Locations (1)

33181

SFBC International, Miami

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00649896 - Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day | Biotech Hunter | Biotech Hunter